, 2018 Hang Yuan,* Ping Cao,* Hai-Liang Li, Hong-Tao Hu, Chen-Yang Guo, Yan Zhao, Quan-Jun Yao, Xiang Geng Minimally Invasive and Interventional Department, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China ...
Hu HT +7 more
core
, 2002 This randomized, controlled trial assessed the efficacy of transarterial Lipiodol (Lipiodol Ultrafluide, Laboratoire Guerbet, Aulnay-Sous-Bois, France) chemoembolization in patients with unresectable hepatocellular carcinoma.
Lo, CM +7 more
core +1 more source
Assessment for Retreatment with Transarterial Chemoembolization Score Effectiveness for Selecting Hepatocelullar Carcinoma Patients Undergoing Repeated Therapy (ART Score Predicting Repeated TACE Impact on Overall Survival) [PDF]
, 2020 Repeated transarterial chemoembolization (TACE) treatment is often needed to increase tumor response and survival of unresectable hepatocellular carcinoma (HCC) patients. However, not all patients experience similar benefit from retreatment.
Budi Widodo +11 more
core +1 more source
BiomedicinesHepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with an average five-year survival rate in the US of 19.6%.
Stephen Susman +2 more
doaj +1 more source
Hepatic arterial chemoembolization for management of metastatic melanoma
, 2008 Hepatic arterial chemoembolization is an accepted therapy for stage 4 melanoma with liver-dominant metastasis. However, the reports of outcomes are limited.
Dayani, Pouya N +6 more
core +1 more source
, 2015 Jian-Hong Zhong,1,2 Bang-De Xiang,1,2 Le-Qun Li1,2 1Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Guangxi Liver Cancer Diagnosis and Treatment Engineering and ...
Xiang BD, Li LQ, Zhong JH
core
Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow-up
, 1996 PURPOSE: To evaluate the efficacy of repeated chemoembolization in patients with inoperable hepatocellular carcinoma (HCC). PATIENTS AND METHODS: One hundred thirty-two patients with HCC underwent transcatheter arterial chemoembolization with an emulsion
Yuen, WK +5 more
core +1 more source
The prime time for management of hepatocellular carcinoma in Hong Kong [PDF]
Clinical and Molecular Hepatology, 2023 Landon L. Chan, Stephen L. Chan
doaj +1 more source
Technical update on transcatheter arterial chemoembolization
, 2019 Transcatheter arterial chemoembolization has become an established drug delivery system for palliative or bridging treatment of hepatocellular carcinoma.
Puppala, Sapna
core
Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis [PDF]
Jiayun Jiang,1 Hui Zhang,1 Jiejuan Lai,1 Shiyu Zhang,1 Yanjiao Ou,1 Yu Fu,2,* Leida Zhang1,* 1Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, People’s Republic of ...
Jiang J +6 more
core